Echo IQ is trading 8.39% down at A$0.71 on September 21, 2026, with no clear company-specific announcement identified.

  • The latest material update on September 17 outlined an FDA appeal, Ombudsman review, or new 510(k) pathway following the EchoSolv HF NSE determination.
  • The decline followed unusually volatile trading after a sharp September 17–18 rebound; broader market conditions were broadly neutral.
  • The specific reason for the September 21 decline remains unclear.